Prof Christopher Rowe of Austin Melbourne, was the guest speaker addressing an audience of nuclear medicine professionals about the latest advancements in the development of amyloid biomarkers. Prof Rowe is a highly respected keynote speaker for the ANZ Society of Geriatric Medicine and is an internationally recognised researcher and developer of new compounds who works closely with international firms to develop novel products.